Topical Corticosteroid Concerns Among Parents of Children with Psoriasis versus Atopic Dermatitis: A French Multicenter Cross-Sectional Study

Moawad, S.; Mahé, E.; Aubert-Wastiaux, Hélène; Phan, Alice; Maruani, Annabel; Chiavérini, C.; Bodemer, Christine; Mazereeuw‐Hautier, J.; Lasek‐Duriez, A.; Droitcourt, Catherine; Barbarot, S.; Beauchet, Alain; Bursztejn, Anne‐Claire

doi:10.1007/s40257-017-0318-5

Cited by 19 publications

(22 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies (12,13) have found that parents of girls had a higher TOPICOP score, while another study (5) found that mothers had higher TOPICOP scores. A study of adults and children with various skin conditions also found that female participants had greater steroid phobia.…”

Section: Discussionmentioning

confidence: 99%

“…It was also recently used to assess steroid phobia associated with psoriasis. (5) Steroid phobia may be partly attributed to the excessive or exaggerated risks depicted by the Internet, family/friends and even medical professionals. A study by Smith et al (6) reported that a third of survey participants received misinformation in the form of exaggerated risks from friends/family and over the Internet.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Corticosteroid phobia: a questionnaire study using TOPICOP score

Choi¹,

Chandran²,

Tan³

2020

smedj

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Corticosteroid phobia: a questionnaire study using TOPICOP score

Choi¹,

Chandran²,

Tan³

2020

smedj

View full text Add to dashboard Cite

“…Corticosteroid phobia is prevalent in dermatology patients and may result in delayed treatment initiation and poor disease control. 7,8,20‐25 . Corticosteroid phobia even exists among healthcare providers, where the highest scores have been found in healthcare nurses, GPs, and pharmacists and the lowest in dermatologists 20,21 .…”

Section: Discussionmentioning

confidence: 99%

“…Atopic dermatitis severity at the time of the survey was assessed using the Patient-Oriented Eczema Measure (POEM) 14 ; a sevenitem, validated, self-reported outcome tool about the frequency of signs and symptoms (itch, sleep disturbance, dryness, flaking, weeping or oozing, bleeding, and cracking) in the past 7 days. The final score ranges from 0 to 28 and was divided into five rank order categories: clear or almost clear (0-2), mild (3-7), moderate (8)(9)(10)(11)(12)(13)(14)(15)(16), severe (17)(18)(19)(20)(21)(22)(23)(24), and very severe eczema (25-28). 15…”

Section: Patient-oriented Eczema Measurementioning

confidence: 99%

Healthcare utilization in Danish children with atopic dermatitis and parental topical corticosteroid phobia

Gerner

Haugaard

Vestergaard

et al. 2020

Pediatric Allergy Immunology

View full text Add to dashboard Cite

Background Atopic dermatitis (AD) is a prevalent relapsing inflammatory skin disease. There is currently little knowledge about healthcare utilization and medication use along with parental corticosteroid phobia in relation to severity of pediatric AD. Objectives To study the association between parental‐reported healthcare utilization, medication use, and topical corticosteroid phobia and pediatric AD severity. Methods The study population included all children in Denmark with a diagnostic code of AD (ICD‐10 code, group L20) given at a hospital department of dermatology between 2014 and 2018. A questionnaire containing 158 response items was sent to the legal parents. We surveyed disease severity, AD treatment, corticosteroid phobia, and healthcare use along with other variables. Disease severity was assessed using the Patient‐Oriented Eczema Measure tool, and corticosteroid phobia was assessed using the Topical Corticosteroid Phobia (TOPICOP) score. Results In total, 1343 (39%) parents completed the questionnaire and 95.3% were completed by the biological mother. Children's mean age was 8.9 ± 4.5 years, and 52.8% were boys. Severe AD was associated with a higher number of healthcare visits to GPs, private dermatologists, and hospital departments. Mean global TOPICOP score was 38.27 ± 19.9%. There was a significant inverse linear trend between global TOPICOP score and parental educational level (Ptrend < .0005). Conclusions The significant association between high global TOPICOP score and low parental educational level, resulting in delayed treatment of AD flares, indicates that improved family education ultimately may reduce healthcare expenses and burden of disease.

show abstract

“…13,14 Recently, this scale has also been used to assess steroid phobia associated with psoriasis. 15 Steroid phobia can be partially attributed to the significant (or overstated) risks presented by the Internet, friends or family, and even medical professionals. The questionnaire-based study by Smith et al reported that 33% of participants had received false information in the form of overstated risks conveyed by friends, family, and the Internet.…”

mentioning

confidence: 99%

The effects of topical steroid fears and concerns on patients with eczema: first TOPICOP© scale-based study in Saudi Arabia

Alharbi¹,

Alhetheli

Alqahtani

et al. 2021

Int J Res Dermatol

View full text Add to dashboard Cite

Background: Topical corticosteroids (TCS) are the main treatment for eczema, which are often required for months (or years) to control the disease. Despite the well-known side effects of TCS, their efficacy and safety are well established when used appropriately. This study was conducted to assess the fears, concerns, and various practices of patients with eczema toward TCS in the Qassim region of Saudi Arabia.Methods: A cross-sectional survey-based study was conducted that targeted patients with eczema among all age groups and genders attending the dermatology outpatient clinics. There were no exclusions based on the type, severity, or duration of the disease.Results: A total of 105 patients with eczema were recruited for this study. It was revealed that 46.8% of participants stopped their treatment as soon as possible, which indicates immediate discontinuation of steroids after their eczema flares had subsided and improved. An interesting finding was that 38.3% of participants did not start their TCS treatment until the disease deteriorated rather than when flare-ups occurred.Conclusions: Exaggerated fears about TCS exist among patients with eczema and their care givers. This can result in non-adherence or wasting of many prescribed TCS preparations TCS. It is very important to understand and emphasize on the nature and extent of the prevalence of TCS fears to ensure that prompt, correct advice can be offered. Since dermatologists remain the most trusted source of information, there should be an emphasis on individual patient counseling and increased engagement in social media with pre-planned content.

show abstract

Topical Corticosteroid Concerns Among Parents of Children with Psoriasis versus Atopic Dermatitis: A French Multicenter Cross-Sectional Study

Cited by 19 publications

References 19 publications

Corticosteroid phobia: a questionnaire study using TOPICOP score

Corticosteroid phobia: a questionnaire study using TOPICOP score

Healthcare utilization in Danish children with atopic dermatitis and parental topical corticosteroid phobia

The effects of topical steroid fears and concerns on patients with eczema: first TOPICOP© scale-based study in Saudi Arabia

Contact Info

Product

Resources

About